Harvard Management Co Inc increased its stake in Facebook Inc (FB) by 2271.44% based on its latest 2018Q3 regulatory filing with the SEC. Harvard Management Co Inc bought 314,821 shares as the company’s stock declined 13.60% with the market. The hedge fund held 328,681 shares of the technology company at the end of 2018Q3, valued at $54.06M, up from 13,860 at the end of the previous reported quarter. Harvard Management Co Inc who had been investing in Facebook Inc for a number of months, seems to be bullish on the $474.85 billion market cap company. The stock decreased 2.41% or $4.11 during the last trading session, reaching $166.38. About 63,656 shares traded. Facebook, Inc. (NASDAQ:FB) has declined 21.26% since February 8, 2018 and is downtrending. It has underperformed by 21.26% the S&P500. Some Historical FB News: 24/04/2018 – Questions about Facebook personal data mining persist; 21/05/2018 – Facebook said it looked forward to the meeting and was happy for it to be live-streamed; 22/03/2018 – Read Mark Zuckerberg’s full statement on Facebook’s privacy scandal:; 08/05/2018 – Facebook shakes up its execs and adds new blockchain group; 10/04/2018 – Zuckerberg says Facebook is working with special counsel Mueller in probe; 12/04/2018 – Recode’s Teddy Schleifer on Spotify’s IPO and Kurt Wagner on Facebook and Cambridge Analytica #TooEmbarrassed (transcript); 20/03/2018 – Facebook CEO Mark Zuckerberg is an “emperor for life” and not accountable to anybody, says Yale’s Jeff Sonnenfeld; 26/03/2018 – Facebook has come under intense scrutiny from users, lawmakers and investors following allegations from a whistleblower that it allowed British political consultancy Cambridge Analytica to improperly use data; 27/03/2018 – Facebook CEO Said to Testify Before House Committee on April 12 (Video); 22/05/2018 – GOOD NEWS ON CAMBRIDGE ANALYTICA IS THAT WOULD NO LONGER BE POSSIBLE SINCE 2014 FOR APP DEVELOPER TO ACCESS THAT LEVEL OF DATA-ZUCKERBERG

Armstrong Henry H Associates Inc increased its stake in Medtronic Plc (MDT) by 4.85% based on its latest 2018Q3 regulatory filing with the SEC. Armstrong Henry H Associates Inc bought 10,045 shares as the company’s stock declined 0.92% with the market. The institutional investor held 217,262 shares of the electromedical & electrotherapeutic apparatus company at the end of 2018Q3, valued at $21.37 million, up from 207,217 at the end of the previous reported quarter. Armstrong Henry H Associates Inc who had been investing in Medtronic Plc for a number of months, seems to be bullish on the $119.40 billion market cap company. The stock increased 0.05% or $0.04 during the last trading session, reaching $88.9. About 4.30M shares traded. Medtronic plc (NYSE:MDT) has risen 18.51% since February 8, 2018 and is uptrending. It has outperformed by 18.51% the S&P500. Some Historical MDT News: 23/04/2018 – ARCA biopharma and Medtronic Extend Gencaro Clinical Trial Collaboration Agreement; 03/05/2018 – lntact Vascular Announces Enrollment Completion of the Tack Optimized Balloon Angioplasty lll (TOBA lll) Clinical Trial; 11/04/2018 – Medtronic Presenting at Conference Apr 11; 12/03/2018 – MEDTRONIC GETS FDA APPROVAL FOR GUARDIAN CONNECT CONTINUOUS GLU; 16/05/2018 – MEDTRONIC RECEIVED IDE APPROVAL FROM FDA TO RESOLUTE ONYX DES; 16/05/2018 – Detailed Research: Economic Perspectives on Medtronic, NVIDIA, NutriSystem, AmTrust Financial Services, Kratos Defense & Securi; 07/05/2018 – Medtronic Names Mike Weinstein Senior Vice President, Strategy; 02/05/2018 – IGNORE: MEDTRONIC’S INFUSE APPROVAL ANNOUNCED APRIL 30; 10/04/2018 – Medtronic Expands Visualase(TM) MRI-Guided Laser Ablation System to European Markets with CE Mark Approval; 10/05/2018 – JPMorgan Adds Aptiv, Cuts Apple, Buys More Medtronic: 13F

More notable recent Facebook, Inc. (NASDAQ:FB) news were published by: Nasdaq.com which released: “Pre-Market Most Active for Jan 31, 2019 : GE, NOK, FB, LYG, AMD, VALE, SQQQ, DWDP, MSFT, QQQ, TQQQ, MA – Nasdaq” on January 31, 2019, also with their article: “Facebook, Inc. (NASDAQ:FB) big, beautiful, and ranked from 1 to 50 – Live Trading News” published on January 28, 2019, Nasdaq.com published: “Notable Thursday Option Activity: AAPL, FB, EW – Nasdaq” on February 07, 2019. More interesting news about Facebook, Inc. (NASDAQ:FB) were released by: and their article: “Facebook sheds gains alongside report alleging account fakery – Seeking Alpha” published on January 24, 2019 as well as ‘s news article titled: “Valuation Of Facebook In Terms Of Expectations For Q4 – Seeking Alpha” with publication date: January 17, 2019.

Since August 13, 2018, it had 0 insider purchases, and 55 selling transactions for $579.35 million activity. Another trade for 55,000 shares valued at $9.94 million was sold by Sandberg Sheryl. Schroepfer Michael Todd sold 38,164 shares worth $5.45 million. Shares for $907,786 were sold by Cox Christopher K. 360,000 Facebook, Inc. (NASDAQ:FB) shares with value of $62.24M were sold by Zuckerberg Mark. FISCHER DAVID B. also sold $392,937 worth of Facebook, Inc. (NASDAQ:FB) on Monday, October 29. $294,835 worth of Facebook, Inc. (NASDAQ:FB) was sold by Taylor Susan J.S..

Among 57 analysts covering Facebook (NASDAQ:FB), 48 have Buy rating, 2 Sell and 7 Hold. Therefore 84% are positive. Facebook had 315 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of Facebook, Inc. (NASDAQ:FB) has “Overweight” rating given on Wednesday, October 31 by Morgan Stanley. The stock has “Hold” rating by BMO Capital Markets on Wednesday, November 22. Stifel Nicolaus maintained the stock with “Buy” rating in Thursday, November 5 report. The stock of Facebook, Inc. (NASDAQ:FB) has “Buy” rating given on Thursday, July 30 by Mizuho. The stock of Facebook, Inc. (NASDAQ:FB) has “Buy” rating given on Thursday, January 31 by Deutsche Bank. The stock of Facebook, Inc. (NASDAQ:FB) has “Buy” rating given on Tuesday, September 26 by Cantor Fitzgerald. The stock of Facebook, Inc. (NASDAQ:FB) has “Buy” rating given on Thursday, April 28 by Axiom Capital. The stock of Facebook, Inc. (NASDAQ:FB) earned “Buy” rating by FBN Securities on Thursday, July 27. The company was maintained on Thursday, April 28 by JP Morgan. Morgan Stanley maintained it with “Overweight” rating and $120 target in Thursday, November 5 report.

Investors sentiment increased to 1.13 in Q3 2018. Its up 0.04, from 1.09 in 2018Q2. It is positive, as 123 investors sold FB shares while 598 reduced holdings. 154 funds opened positions while 661 raised stakes. 1.61 billion shares or 3.39% less from 1.66 billion shares in 2018Q2 were reported. Louisiana State Employees Retirement System, a Louisiana-based fund reported 141,100 shares. High Pointe Cap Management Limited Com owns 2,085 shares for 0.46% of their portfolio. Moreover, Carlson Ltd Partnership has 0.56% invested in Facebook, Inc. (NASDAQ:FB) for 275,116 shares. Ubs Oconnor Ltd Liability invested 0% of its portfolio in Facebook, Inc. (NASDAQ:FB). 16.45 million are owned by Ameriprise Financial. Front Barnett Assoc Ltd Com reported 2,503 shares stake. Private Ocean Lc reported 1,075 shares stake. Wilbanks Smith Thomas Asset Mgmt Ltd Co reported 0.09% stake. 111,601 are owned by Washington. Lpl Fincl Ltd holds 773,668 shares. 4.75 million are held by Prudential. First Personal Fin Services has 2,212 shares. 49,555 are held by Timessquare Capital Limited. Alps Advsr, a Colorado-based fund reported 32,990 shares. Hendershot Investments reported 1.95% stake.

Harvard Management Co Inc, which manages about $392.03 million US Long portfolio, decreased its stake in Apple Inc (NASDAQ:AAPL) by 411,039 shares to 107,903 shares, valued at $24.36 million in 2018Q3, according to the filing.

More notable recent Medtronic plc (NYSE:MDT) news were published by: Seekingalpha.com which released: “Medtronic execs buy shares – Seeking Alpha” on January 09, 2019, also Seekingalpha.com with their article: “Medtronic launches new spine surgery system in U.S. – Seeking Alpha” published on January 28, 2019, Seekingalpha.com published: “Medtronic up 1% premarket on superDimension data – Seeking Alpha” on January 30, 2019. More interesting news about Medtronic plc (NYSE:MDT) were released by: Globenewswire.com and their article: “Medtronic to Acquire EPIX Therapeutics, Expanding Its Cardiac Ablation Portfolio – GlobeNewswire” published on January 24, 2019 as well as ‘s news article titled: “BTIG Says Buy The Dip In Medtronic (NYSE:MDT) – Benzinga” with publication date: January 15, 2019.

Investors sentiment increased to 1.07 in 2018 Q3. Its up 0.09, from 0.98 in 2018Q2. It improved, as 24 investors sold MDT shares while 440 reduced holdings. 140 funds opened positions while 355 raised stakes. 1.02 billion shares or 0.96% less from 1.03 billion shares in 2018Q2 were reported. Hanson Mcclain holds 0.03% in Medtronic plc (NYSE:MDT) or 7,196 shares. Northstar Gru has 5,228 shares. Raub Brock Capital Ltd Partnership has invested 4.43% in Medtronic plc (NYSE:MDT). Bellecapital stated it has 0.5% of its portfolio in Medtronic plc (NYSE:MDT). Mitsubishi Ufj Secs Hldgs Ltd invested in 130 shares. Ancora Advsr Ltd Liability reported 101,859 shares or 0.39% of all its holdings. Wedge L LP Nc has invested 0% in Medtronic plc (NYSE:MDT). Art Advsr Limited Liability reported 15,100 shares. Boston stated it has 6.64M shares. Optimum owns 2,291 shares for 0.06% of their portfolio. Provise Mgmt Gp Ltd Liability Co accumulated 2,050 shares. Moreover, Cibc Asset Mgmt has 0.09% invested in Medtronic plc (NYSE:MDT) for 139,743 shares. Moreover, Pittenger And Anderson has 0.22% invested in Medtronic plc (NYSE:MDT) for 28,625 shares. Ameritas Invest Ptnrs accumulated 0.16% or 35,556 shares. The Illinois-based State Farm Mutual Automobile has invested 0.41% in Medtronic plc (NYSE:MDT).

Armstrong Henry H Associates Inc, which manages about $460.14M and $651.40M US Long portfolio, decreased its stake in Johnson & Johnson (NYSE:JNJ) by 6,790 shares to 496,872 shares, valued at $68.65M in 2018Q3, according to the filing.